Poly Medicure Ltd.

•
₹ 1,719.4-2.84%

2026-08-21

polymedicure.comBSE: 531768NSE: POLYMED
Market Cap₹ 17,957 Cr.
Current Price₹ 1,770
High / Low₹ 2,145 / 1,182
Stock P/E57.0
Book Value₹ 314
Price to Book3.90
Dividend Yield0.20 %
ROCE14.0 %
ROE10.9 %
Face Value₹ 5

Add ratio to table

ABOUT

KEY POINTS

Revenue Breakup Mar 2023 • Medical Devices: 100.0%

PROS

  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 19.0% CAGR over last 5 years
  • Company comfortably covers its interest (21.0x coverage)
  • Working capital cycle has improved - days down from 338 to 264
  • Company has a consistent dividend-paying track record
  • Company generates healthy free cash flow

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • Recent results are weak - TTM profit is down 15.4% versus prior year
  • A large part of profit comes from other income (29.7% of PBT)
  • Promoter holding has decreased over last 2 years: -3.6pp
  • Total debt has risen sharply - up 92.3% year on year
  • Operating margins have contracted to 23.2% from 27.1%

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
HealthcareHealthcareMedical Equipment/Supplies/Accessories
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.LENSKART639.30169.67111193.840.002284.303634.3527141.801332.6912.5521.70
2.POLYMED1771.6056.9917957.200.2085.27-8.39525.3830.3014.0524.11
3.MOLBIO1040.3571.9711988.990.00————19.79—
4.LAXMIDENTL195.6534.851076.500.0010.3223.8374.7016.1324.9620.26
5.3BBLACKBIO1145.5517.71983.190.448.98-28.9933.4950.5926.0325.45
6.GKB63.959.9432.230.001.85387.9933.042.268.827.97
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023
321
234
Operating Profit
—
OPM %
—
Other Income
13
Interest
2
Depreciation
16
82
Tax %
24.73%
Net Profit
0
7
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
337
253
Operating Profit
—
OPM %
—
Other Income
14
Interest
2
Depreciation
16
80
Tax %
23.42%
Net Profit
0
6
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
340
249
Operating Profit
—
OPM %
—
Other Income
17
Interest
3
Depreciation
16
87
Tax %
26.19%
Net Profit
0
7
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
378
282
Operating Profit
—
OPM %
—
Other Income
15
Interest
3
Depreciation
16
92
Tax %
26.13%
Net Profit
0
7
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
385
281
Operating Profit
—
OPM %
—
Other Income
17
Interest
3
Depreciation
20
98
Tax %
24.91%
Net Profit
74
8
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
48
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
420
305
Operating Profit
—
OPM %
—
Other Income
26
Interest
3
Depreciation
21
117
Tax %
26.04%
Net Profit
87
9
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
424
310
Operating Profit
—
OPM %
—
Other Income
22
Interest
3
Depreciation
21
112
Tax %
25.11%
Net Profit
85
8
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
441
321
Operating Profit
—
OPM %
—
Other Income
24
Interest
2
Depreciation
21
121
Tax %
25.73%
Net Profit
92
9
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
403
297
Operating Profit
—
OPM %
—
Other Income
42
Interest
3
Depreciation
23
122
Tax %
24.55%
Net Profit
93
9
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
444
329
Operating Profit
—
OPM %
—
Other Income
34
Interest
3
Depreciation
25
121
Tax %
24.76%
Net Profit
92
9
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
494
382
Operating Profit
—
OPM %
—
Other Income
26
Interest
6
Depreciation
29
96
Tax %
27.94%
Net Profit
71
7
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
535
424
Operating Profit
—
OPM %
—
Other Income
18
Interest
6
Depreciation
38
84
Tax %
24.16%
Net Profit
65
7
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
525
443
Operating Profit
—
OPM %
—
Other Income
33
Interest
7
Depreciation
36
117
Tax %
27.31%
Net Profit
85
1
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
51
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
455
362
Operating Profit
107
OPM %
24
Other Income
14
Interest
9
Depreciation
24
75
Tax %
27
Net Profit
55
EPS
6
Dividend Payout %
40
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Minority Interest
0
Share of Associates
0
Adjusted EPS
6
Mar 2018
520
398
Operating Profit
136
OPM %
26
Other Income
14
Interest
12
Depreciation
29
97
Tax %
27
Net Profit
71
EPS
8
Dividend Payout %
25
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Minority Interest
0
Share of Associates
0
Adjusted EPS
8
Mar 2019
611
480
Operating Profit
150
OPM %
25
Other Income
18
Interest
14
Depreciation
37
100
Tax %
35
Net Profit
65
EPS
7
Dividend Payout %
27
Minority Interest
0
Share of Associates
0
Adjusted EPS
7
Minority Interest
0
Share of Associates
0
Adjusted EPS
7
Mar 2020
687
521
Operating Profit
185
OPM %
27
Other Income
18
Interest
20
Depreciation
41
126
Tax %
24
Net Profit
96
EPS
11
Dividend Payout %
18
Minority Interest
0
Share of Associates
0
Adjusted EPS
11
Minority Interest
0
Share of Associates
0
Adjusted EPS
11
Mar 2021
786
570
Operating Profit
235
OPM %
30
Other Income
18
Interest
11
Depreciation
48
180
Tax %
25
Net Profit
136
EPS
15
Dividend Payout %
18
Minority Interest
0
Share of Associates
0
Adjusted EPS
14
Minority Interest
0
Share of Associates
0
Adjusted EPS
14
Mar 2022
923
708
Operating Profit
253
OPM %
27
Other Income
38
Interest
6
Depreciation
54
195
Tax %
25
Net Profit
147
EPS
15
Dividend Payout %
16
Minority Interest
0
Share of Associates
0
Adjusted EPS
15
Minority Interest
0
Share of Associates
0
Adjusted EPS
15
Mar 2023
1,115
848
Operating Profit
304
OPM %
27
Other Income
36
Interest
11
Depreciation
57
237
Tax %
25
Net Profit
179
EPS
19
Dividend Payout %
16
Minority Interest
0
Share of Associates
0
Adjusted EPS
19
Minority Interest
0
Share of Associates
0
Adjusted EPS
19
Mar 2024
1,376
1,016
Operating Profit
419
OPM %
30
Other Income
59
Interest
14
Depreciation
63
344
Tax %
25
Net Profit
258
EPS
27
Dividend Payout %
11
Minority Interest
0
Share of Associates
0
Adjusted EPS
27
Minority Interest
0
Share of Associates
0
Adjusted EPS
27
Mar 2025
1,670
1,214
Operating Profit
545
OPM %
33
Other Income
89
Interest
14
Depreciation
83
453
Tax %
25
Net Profit
339
EPS
33
Dividend Payout %
10
Minority Interest
0
Share of Associates
0
Adjusted EPS
33
Minority Interest
0
Share of Associates
0
Adjusted EPS
33
Mar 2026
1,875
1,437
Operating Profit
566
OPM %
30
Other Income
127
Interest
21
Depreciation
116
427
Tax %
25
Net Profit
321
EPS
32
Dividend Payout %
11
Minority Interest
1
Share of Associates
0
Adjusted EPS
32
Minority Interest
1
Share of Associates
0
Adjusted EPS
32
TTM
1,997
1,579
Operating Profit
—
OPM %
—
Other Income
111
Interest
22
Depreciation
128
417
Tax %
26
Net Profit
309
EPS
—
Dividend Payout %
—
Minority Interest
-1
Share of Associates
6
Adjusted EPS
—
Minority Interest
-1
Share of Associates
6
Adjusted EPS
—

COMPOUNDED SALES GROWTH

10 Years:
16%
5 Years:
19%
3 Years:
19%

COMPOUNDED PROFIT GROWTH

10 Years:
21%
5 Years:
19%
3 Years:
22%

STOCK PRICE CAGR

10 Years:
25%
5 Years:
14%
3 Years:
7%
1 Year:
-10%

RETURN ON EQUITY

10 Years:
18%
5 Years:
15%
3 Years:
15%
Last Year:
11%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2017

Mar 24

1:1

Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 06, 2017, inter alia, to consider the following: 1. To consider and approve the Un-Audited Financial Results of the Company for the Third quarter and Nine months ended on December 31, 2016. 2. To consider declaration of 2nd interim dividend, to the Equity Shareholders of the Company for the current financial year 2016-17. 3. To consider the issue of Bonus Shares, subject to approval of shareholdeis to be obtained in this behalf.

Mar 2017
Equity Capital
44
227
53
Trade Payables
42
91
Total Liabilities
457
206
Capital Work in Progress
12
3
62
0
Cash & Bank
23
151
Total Assets
457
Total Debt
101
Net Working Capital
91
Contingent Liabilities
39
Book Value per Share
30.75
Face Value
5.00
Total Debt
101
Net Working Capital
91
Contingent Liabilities
39
Book Value per Share
30.75
Face Value
5.00
Mar 2018
Equity Capital
44
294
54
Trade Payables
44
130
Total Liabilities
565
262
Capital Work in Progress
10
17
73
0
Cash & Bank
20
183
Total Assets
565
Total Debt
133
Net Working Capital
133
Contingent Liabilities
42
Book Value per Share
38.30
Face Value
5.00
Total Debt
133
Net Working Capital
133
Contingent Liabilities
42
Book Value per Share
38.30
Face Value
5.00
Mar 2019
Equity Capital
44
337
69
Trade Payables
56
176
Total Liabilities
682
303
Capital Work in Progress
9
8
84
0
Cash & Bank
55
224
Total Assets
682
Total Debt
161
Net Working Capital
148
Contingent Liabilities
37
Book Value per Share
43.19
Face Value
5.00
Total Debt
161
Net Working Capital
148
Contingent Liabilities
37
Book Value per Share
43.19
Face Value
5.00
Mar 2020
Equity Capital
44
391
88
Trade Payables
66
211
Total Liabilities
800
359
Capital Work in Progress
17
25
112
0
Cash & Bank
25
261
Total Assets
800
Total Debt
202
Net Working Capital
125
Contingent Liabilities
58
Book Value per Share
49.26
Face Value
5.00
Total Debt
202
Net Working Capital
125
Contingent Liabilities
58
Book Value per Share
49.26
Face Value
5.00
Mar 2021
Equity Capital
48
917
71
Trade Payables
65
167
Total Liabilities
1,267
421
Capital Work in Progress
15
354
126
0
Cash & Bank
30
321
Total Assets
1,267
Total Debt
134
Net Working Capital
533
Contingent Liabilities
64
Book Value per Share
100.62
Face Value
5.00
Total Debt
134
Net Working Capital
533
Contingent Liabilities
64
Book Value per Share
100.62
Face Value
5.00
Mar 2022
Equity Capital
48
1,038
87
Trade Payables
89
115
Total Liabilities
1,377
484
Capital Work in Progress
37
346
168
0
Cash & Bank
15
325
Total Assets
1,377
Total Debt
125
Net Working Capital
557
Contingent Liabilities
69
Book Value per Share
113.24
Face Value
5.00
Total Debt
125
Net Working Capital
557
Contingent Liabilities
69
Book Value per Share
113.24
Face Value
5.00
Mar 2023
Equity Capital
48
1,191
129
Trade Payables
92
175
Total Liabilities
1,635
634
Capital Work in Progress
73
132
209
0
Cash & Bank
178
410
Total Assets
1,635
Total Debt
146
Net Working Capital
513
Contingent Liabilities
69
Book Value per Share
129.17
Face Value
5.00
Total Debt
146
Net Working Capital
513
Contingent Liabilities
69
Book Value per Share
129.17
Face Value
5.00
Mar 2024
Equity Capital
48
1,419
151
Trade Payables
96
219
Total Liabilities
1,932
867
Capital Work in Progress
67
167
221
270
Cash & Bank
147
194
Total Assets
1,932
Total Debt
170
Net Working Capital
490
Contingent Liabilities
113
Book Value per Share
152.82
Face Value
5.00
Total Debt
170
Net Working Capital
490
Contingent Liabilities
113
Book Value per Share
152.82
Face Value
5.00
Mar 2025
Equity Capital
51
2,713
175
Trade Payables
86
255
Total Liabilities
3,280
1,084
Capital Work in Progress
90
1,076
286
350
Cash & Bank
151
243
Total Assets
3,280
Total Debt
178
Net Working Capital
1,552
Contingent Liabilities
77
Book Value per Share
272.72
Face Value
5.00
Total Debt
178
Net Working Capital
1,552
Contingent Liabilities
77
Book Value per Share
272.72
Face Value
5.00
Mar 2026
Equity Capital
51
3,048
262
Trade Payables
123
452
Total Liabilities
3,936
1,694
Capital Work in Progress
91
755
434
531
Cash & Bank
88
344
Total Assets
3,936
Total Debt
342
Net Working Capital
1,366
Contingent Liabilities
50
Book Value per Share
305.72
Face Value
5.00
Total Debt
342
Net Working Capital
1,366
Contingent Liabilities
50
Book Value per Share
305.72
Face Value
5.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
56
Cash from Investing
-56
Cash from Financing
-0
0
Free Cash Flow
1
OCF / Net Profit
1.02
Cumulative 5-Year FCF
0
OCF / Net Profit
1.02
Cumulative 5-Year FCF
0
Mar 2018
75
Cash from Investing
-88
Cash from Financing
16
3
Free Cash Flow
-9
OCF / Net Profit
1.06
Cumulative 5-Year FCF
0
OCF / Net Profit
1.06
Cumulative 5-Year FCF
0
Mar 2019
106
Cash from Investing
-101
Cash from Financing
-5
1
Free Cash Flow
29
OCF / Net Profit
1.63
Cumulative 5-Year FCF
0
OCF / Net Profit
1.63
Cumulative 5-Year FCF
0
Mar 2020
128
Cash from Investing
-107
Cash from Financing
-21
1
Free Cash Flow
29
OCF / Net Profit
1.34
Cumulative 5-Year FCF
0
OCF / Net Profit
1.34
Cumulative 5-Year FCF
0
Mar 2021
119
Cash from Investing
-436
Cash from Financing
317
0
Free Cash Flow
13
OCF / Net Profit
0.87
Cumulative 5-Year FCF
64
OCF / Net Profit
0.87
Cumulative 5-Year FCF
64
Mar 2022
123
Cash from Investing
-85
Cash from Financing
-35
3
Free Cash Flow
-10
OCF / Net Profit
0.84
Cumulative 5-Year FCF
53
OCF / Net Profit
0.84
Cumulative 5-Year FCF
53
Mar 2023
191
Cash from Investing
-179
Cash from Financing
-13
-1
Free Cash Flow
-45
OCF / Net Profit
1.07
Cumulative 5-Year FCF
17
OCF / Net Profit
1.07
Cumulative 5-Year FCF
17
Mar 2024
266
Cash from Investing
-241
Cash from Financing
-20
5
Free Cash Flow
-20
OCF / Net Profit
1.03
Cumulative 5-Year FCF
-33
OCF / Net Profit
1.03
Cumulative 5-Year FCF
-33
Mar 2025
233
Cash from Investing
-1,187
Cash from Financing
951
-4
Free Cash Flow
-75
OCF / Net Profit
0.69
Cumulative 5-Year FCF
-137
OCF / Net Profit
0.69
Cumulative 5-Year FCF
-137
Mar 2026
246
Cash from Investing
-225
Cash from Financing
20
41
Free Cash Flow
-635
OCF / Net Profit
0.77
Cumulative 5-Year FCF
-784
OCF / Net Profit
0.77
Cumulative 5-Year FCF
-784

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017
EPS (₹)
6.25
Book Value (₹)
30.75
Dividend per Share (₹)
2.50
Cash EPS (₹)
8.94
Operating Margin %
23.17%
Net Margin %
11.94%
ROE %
22.05%
ROCE %
24.54%
13.06%
Debtor Days
71
Inventory Days
43
Payable Days
114
0
Debt to Equity (x)
0.37x
Interest Coverage (x)
9.67x
1.80x
Revenue Growth %
10.37%
Operating Profit Growth %
11.43%
Net Profit Growth %
16.12%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
8.00
Book Value (₹)
38.30
Dividend per Share (₹)
2.00
Cash EPS (₹)
11.32
Operating Margin %
26.13%
Net Margin %
13.53%
ROE %
23.18%
ROCE %
25.69%
13.82%
Debtor Days
73
Inventory Days
47
Payable Days
125
-5
Debt to Equity (x)
0.39x
Interest Coverage (x)
9.36x
2.08x
Revenue Growth %
14.38%
Operating Profit Growth %
27.42%
Net Profit Growth %
28.06%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
7.41
Book Value (₹)
43.19
Dividend per Share (₹)
2.00
Cash EPS (₹)
11.64
Operating Margin %
24.38%
Net Margin %
10.65%
ROE %
18.19%
ROCE %
22.47%
10.49%
Debtor Days
72
Inventory Days
47
Payable Days
110
8
Debt to Equity (x)
0.42x
Interest Coverage (x)
8.28x
1.82x
Revenue Growth %
17.37%
Operating Profit Growth %
9.81%
Net Profit Growth %
-7.36%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
10.86
Book Value (₹)
49.26
Dividend per Share (₹)
2.00
Cash EPS (₹)
15.46
Operating Margin %
26.74%
Net Margin %
13.89%
ROE %
23.51%
ROCE %
24.80%
12.95%
Debtor Days
68
Inventory Days
52
Payable Days
131
-12
Debt to Equity (x)
0.47x
Interest Coverage (x)
7.14x
1.55x
Revenue Growth %
12.51%
Operating Profit Growth %
23.29%
Net Profit Growth %
46.60%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
14.17
Book Value (₹)
100.62
Dividend per Share (₹)
2.50
Cash EPS (₹)
19.13
Operating Margin %
29.72%
Net Margin %
17.19%
ROE %
19.42%
ROCE %
21.96%
13.15%
Debtor Days
65
Inventory Days
55
Payable Days
112
8
Debt to Equity (x)
0.14x
Interest Coverage (x)
17.92x
3.48x
Revenue Growth %
14.44%
Operating Profit Growth %
27.26%
Net Profit Growth %
41.72%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
15.28
Book Value (₹)
113.24
Dividend per Share (₹)
2.50
Cash EPS (₹)
20.90
Operating Margin %
27.27%
Net Margin %
15.80%
ROE %
14.29%
ROCE %
17.42%
11.08%
Debtor Days
71
Inventory Days
58
Payable Days
100
30
Debt to Equity (x)
0.12x
Interest Coverage (x)
32.68x
3.46x
Revenue Growth %
17.37%
Operating Profit Growth %
7.67%
Net Profit Growth %
7.82%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
18.69
Book Value (₹)
129.17
Dividend per Share (₹)
3.00
Cash EPS (₹)
24.64
Operating Margin %
27.11%
Net Margin %
16.01%
ROE %
15.42%
ROCE %
19.10%
11.90%
Debtor Days
72
Inventory Days
61
Payable Days
103
31
Debt to Equity (x)
0.12x
Interest Coverage (x)
22.87x
2.46x
Revenue Growth %
20.82%
Operating Profit Growth %
20.04%
Net Profit Growth %
22.37%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
26.91
Book Value (₹)
152.82
Dividend per Share (₹)
3.00
Cash EPS (₹)
33.52
Operating Margin %
26.07%
Net Margin %
18.70%
ROE %
19.09%
ROCE %
23.63%
14.48%
Debtor Days
67
Inventory Days
57
Payable Days
87
36
Debt to Equity (x)
0.12x
Interest Coverage (x)
26.38x
2.15x
Revenue Growth %
23.36%
Operating Profit Growth %
37.93%
Net Profit Growth %
44.05%
44.01%
P/E (x)
59.04x
P/B (x)
10.40x
Dividend Yield %
0.19%
36.47x
Mar 2025
EPS (₹)
33.41
Book Value (₹)
272.72
Dividend per Share (₹)
3.50
Cash EPS (₹)
41.62
Operating Margin %
27.17%
Net Margin %
20.19%
ROE %
16.01%
ROCE %
20.37%
12.99%
Debtor Days
67
Inventory Days
55
Payable Days
74
48
Debt to Equity (x)
0.06x
Interest Coverage (x)
32.59x
4.39x
Revenue Growth %
21.37%
Operating Profit Growth %
30.11%
Net Profit Growth %
31.09%
24.16%
P/E (x)
67.10x
P/B (x)
8.22x
Dividend Yield %
0.16%
41.75x
Mar 2026
EPS (₹)
31.78
Book Value (₹)
305.72
Dividend per Share (₹)
3.50
Cash EPS (₹)
43.04
Operating Margin %
23.24%
Net Margin %
17.00%
ROE %
10.94%
ROCE %
14.05%
8.89%
Debtor Days
85
Inventory Days
70
Payable Days
78
77
Debt to Equity (x)
0.11x
Interest Coverage (x)
20.96x
3.05x
Revenue Growth %
12.30%
Operating Profit Growth %
3.80%
Net Profit Growth %
-5.27%
-4.88%
P/E (x)
37.47x
P/B (x)
3.90x
Dividend Yield %
0.29%
21.79x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
66.03
9.91
9.34
Government
0.00
14.72
Sep 2024
62.56
11.86
12.33
Government
0.00
13.24
Dec 2024
62.44
12.31
11.66
Government
0.00
13.57
Mar 2025
62.44
11.44
11.96
Government
0.00
14.15
Jun 2025
62.44
11.41
11.72
Government
0.00
14.44
Sep 2025
62.42
9.77
13.53
Government
0.00
14.27
Dec 2025
62.42
9.40
13.84
Government
0.00
14.34
Mar 2026
62.42
5.92
15.60
Government
0.00
16.08
Jun 2026
62.42
5.56
16.08
Government
0.00
15.94

Documents

Announcements

  • General Updates

    2026-08-20 - Investor Call Scheedule to be held on 20th August, 2026 is Cancelled

  • General Updates

    2026-08-17 - Poly Medicure Limited has informed the Exchange about the schedule of Investors/Analysts Call/Meet

Annual Reports

Credit Ratings

  • Credit Rating- Revision

    2026-06-26 - Poly Medicure Limited has informed the Exchange about Credit Rating- Outlook Revision and Rating Re-affirmed

Concalls